Tel Aviv University scientists have discovered an enzyme that controls blood glutamate levels and could help patients recover from spinal injuries if administered soon after an accident. Reducing the release of glutamate after a trauma enabled lesions at the injury site to regenerate.
Israeli startup Amai Proteins has synthesized the protein thaumatin, found naturally in the Nigerian katemfe plant, which acts as a sweetener but does not raise blood sugar or insulin levels. Amai have conducted initial test tastings and have raised NIS 3 million of funding.
I reported previously ) on Israel’s work to combat Leishmaniasis - a deadly parasitic disease common in the Middle East. Now Professor Shulamit Michaeli, at Israel’s Bar-Ilan University, is working to commercialize a compound that in 20 minutes kills two types of Leishmania parasites.
Israeli scientists have discovered that both positive and negative memories are stored in genes within areas of the brain that can be retrieved even post-mortem. The findings could one day help treat patients with psychiatric disorders such as OCD, schizophrenia and trauma.
I reported previously about Israeli startup CartiHeal which invented the Agili-C knee implant that uses coral-derived material to repair damaged knee cartilage. Doctors at Jerusalem’s Hadassah hospital have just performed the first Israeli Agili-C surgery.
Jacob A’s lower leg was amputated after a work accident. But his foot was fine, so in Israel’s first “rotationplasty” operation, doctors at Haifa’s Rambam hospital turned it upside down and made the ankle joint into a knee joint. Once Jacob has a prosthetic fitted, he should be able to walk normally.
I reported previously on Israeli startup Nobio (previously named Nanolock) and its revolutionary nano-polymer that causes bacteria to die immediately on contact. Nobio has just raised $3.6 million of funds to help it obtain FDA approval. See also new video.
I reported previously on Israeli biotech NewStem which is developing a stem cell platform to test cancer treatments in the lab before potentially wasting them on patients. NewStem has just received $4 million of funds from an unlikely source – Hollywood Media Corp.
British philanthropist David Dangoor writes that Israel is at the forefront of development of personalized medical innovations that can solve prohibitive and largely ineffective medical treatments being used in the UK and elsewhere.
Scientists at Israel’s Weizmann Institute have used a combination of 3 cancer treatments to prevent lung cancer tumors from re-occurring. In laboratory tests, when Tagrisso, Erbitux and Herceptin were used together they prevented the cancer from developing resistance to single treatments.